6 research outputs found
Recommended from our members
Hot melt extrusion (HME) processing for the development of lipid oral solid dosage forms
This research study explores the use of lipids in hot melt extrusion (HME) for the preparation of sustained release solid lipid matrices. The use of lipids instead of polymers is a novel approach with distinct advantageous. Sustained release solid lipid matrices of diclofenac sodium (Df-Na)/Compritol® 888 ATO (888 ATO) prepared using different approaches such as ‘cold’, ‘hot’ and pre-mix’ by applying changes in processing temperature, drug/lipid ratio and composition of the formulation processed by HME and subsequent compression into tablets were investigated. The characterization using differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) exhibited Df-Na either in the crystalline or amorphous state depending on the processing methodology. EDX was employed to validate the homogeneous distribution of drug on the surface of the compressed tablets. Solid lipid matrices exhibited sustained release of pre-mix formulations for 12 hr; mainly via controlled diffusion. Studies were conducted to investigate the impact of processing conditions, addition of excipients, drug loading and drug release rate. The co-extrusion was performed by addition of Fujicalin (DCPA) to the binary mixture. The dissolution rates were found to depend on the actual Df-Na loading and the nature of added excipients, while the effect of the processing temperature was negligible. The dissolution mechanism of all extruded formulations obeyed the Peppas–Korsemeyer law, based on the estimated mechanism of all extruded coefficients and the dissolution constant rates, which reflect drug diffusion from lipid matrices. A supplementary study was performed to investigate the effect of food on in vitro drug release for a pediatric application as an extemporaneous preparation. Uniform size (1mm) pellets of Df-Na/888 ATO were investigated in the presence of different food grades such as yogurt, applesauce, mashed potato and hypromellose 2910 suspension by using a dissolution media at three different pH values. Drug release at pH 1.1 and pH 1.6 showed negligible effects in the presence of food, whilst the drug release at pH 5.5 showed a significant effect. The similarity factor f2 revealed similarity in the release profiles of all foods except hypromellose suspension. Furthermore, mapping techniques (EDX and confocal Raman spectroscopy) were employed, albeit with distinct limitations, to characterize the drug content uniformity and distribution of hot-melt extruded paracetamol (PMOL) tablets. PMOL tablets were obtained using HME extrudates by applying ‘hot’ and ‘pre-mix’ approaches to PMOL/888 ATO at different processing temperatures and different formulation compositions. The results showed better homogeneity and uniformity of PMOL in pre-mix formulation compared to the hot-melt extruded formulation
Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs
Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion
An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems
Purpose: Three-dimensional printing (3DP) is a rapidly growing additive manufacturing process and it is predicted that the technology will transform the production of goods across numerous fields. In the pharmaceutical sector, 3DP has been used to develop complex dosage forms of different sizes and structures, dose variations, dose combinations and release characteristics, not possible to produce using traditional manufacturing methods. However, the technology has mainly been focused on polymer-based systems and currently, limited information is available about the potential opportunities for the 3DP of soft materials such as lipids. / Methods: This review paper emphasises the most commonly used 3DP technologies for soft materials such as inkjet printing, binder jetting, selective laser sintering (SLS), stereolithography (SLA), fused deposition modeling (FDM) and semi-solid extrusion, with the current status of these technologies for soft materials in biological, food and pharmaceutical applications. / Result: The advantages of 3DP, particularly in the pharmaceutical field, are highlighted and an insight is provided about the current studies for lipid-based drug delivery systems evaluating the potential of 3DP to fabricate innovative products. Additionally, the challenges of the 3DP technologies associated with technical processing, regulatory and material issues of lipids are discussed in detail. / Conclusion: The future utility of 3DP for printing soft materials, particularly for lipid-based drug delivery systems, offers great advantages and the technology will potentially support patient compliance and drug effectiveness via a personalised medicine approach